Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4)
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 295, Issue 8, Pages 2520-2540
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2020-01-01
DOI
10.1074/jbc.ra119.011461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Intrinsic Hydrophobicity Scale for Amino Acids and Its Application to Fluorinated Compounds
- (2019) Waldemar Hoffmann et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential
- (2019) Mohammad Seyedabadi et al. PHARMACOLOGY & THERAPEUTICS
- The EMBL-EBI search and sequence analysis tools APIs in 2019
- (2019) Fábio Madeira et al. NUCLEIC ACIDS RESEARCH
- Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy
- (2019) Michael M. Miller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for G Protein–Coupled Receptor Signaling
- (2018) Sarah C. Erlandson et al. Annual Review of Biophysics
- Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet TherapeuticsHighlights
- (2018) Benjamin E. Tourdot et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
- (2018) Gamariel Rwibasira Rudinga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
- (2018) Krishna Sriram et al. MOLECULAR PHARMACOLOGY
- Structure and dynamics of GPCR signaling complexes
- (2018) Daniel Hilger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure and dynamics of GPCR signaling complexes
- (2018) Daniel Hilger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- G Protein–Coupled Receptor Signaling Through β-Arrestin–Dependent Mechanisms
- (2017) Pierre-Yves Jean-Charles et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family
- (2017) Michael J. Woolley et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
- (2017) Rithwik Ramachandran et al. MOLECULAR PHARMACOLOGY
- Structural insight into allosteric modulation of protease-activated receptor 2
- (2017) Robert K. Y. Cheng et al. NATURE
- Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand
- (2017) I. C. Moschonas et al. PLATELETS
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets
- (2017) Daniel Sánchez Centellas et al. THROMBOSIS RESEARCH
- PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
- (2017) Simon J. Wilson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protease-activated receptor 4: from structure to function and back again
- (2016) Shauna L French et al. BRITISH JOURNAL OF PHARMACOLOGY
- RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency
- (2016) Peter Chidiac METHODS
- GalaxyPepDock: a protein–peptide docking tool based on interaction similarity and energy optimization
- (2015) Hasup Lee et al. NUCLEIC ACIDS RESEARCH
- Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
- (2014) L. C. Edelstein et al. BLOOD
- Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease
- (2013) M D Hollenberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Molecular signatures of G-protein-coupled receptors
- (2013) A. J. Venkatakrishnan et al. NATURE
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Lifting the lid on GPCRs: the role of extracellular loops
- (2012) M Wheatley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
- (2012) Benjamin M Scirica et al. LANCET
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potent Agonists of the Protease Activated Receptor 2 (PAR2)
- (2011) Scott Boitano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- Structure, function and pathophysiology of protease activated receptors
- (2011) Mark N. Adams et al. PHARMACOLOGY & THERAPEUTICS
- Signal transduction by protease-activated receptors
- (2010) Unice JK Soh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets
- (2010) Dongjun Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
- (2009) David A. Morrow et al. AMERICAN HEART JOURNAL
- Protease-Activated Receptor 4 Uses Anionic Residues To Interact with α-Thrombin in the Absence or Presence of Protease-Activated Receptor 1†
- (2008) Marvin T. Nieman BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More